All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

11

Reset

11 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SEP-363856UlotarontPhase 37 trials

    Otsuka · Generalized Anxiety Disorder, Schizophrenia, Major Depressive Disorder

  • ITI-1284JNJ-99245354Phase 36 trials

    Intra-Cellular Therapies, Inc. · Generalized Anxiety Disorder, Agitation Associated With Alzheimer's Dementia, Psychotic Disorders

  • DT120MM120, lysergide tartratePhase 34 trials

    Definium Therapeutics US, Inc. · Generalized Anxiety Disorder, Major Depressive Disorder

  • BuagafuranPhase 32 trials

    Beijing Union Pharmaceutical Factory Ltd · Generalized Anxiety Disorder

  • Buagafuran mimicPhase 32 trials

    Beijing Union Pharmaceutical Factory Ltd · Generalized Anxiety Disorder

  • Luye Pharma Group Ltd. · Generalized Anxiety Disorder

  • ABBV-932Phase 23 trials

    AbbVie · Bipolar I or II Disorder, Generalized Anxiety Disorder (GAD), Bipolar I Disorder

  • ENX-102ENX-102 -dose, ENX-102 mid-dosePhase 23 trials

    Engrail Therapeutics INC · General Anxiety Disorder, Social Anxiety Disorder (SAD), Generalized Anxiety Disorder

  • RE104Phase 23 trials

    Reunion Neuroscience Inc · Adjustment Disorder, Generalized Anxiety Disorder, Postpartum Depression

  • CYB004Phase 21 trial

    Cybin IRL Limited · Generalized Anxiety Disorder

  • SYT-510Phase 21 trial

    Synendos Therapeutics AG · Generalized Anxiety Disorder

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.